Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSCB3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,245
Award facts
- Contract value 100% obligated
- $10,245.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,245.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Tymlos 80 MCG Dose Pen Injector 1.56ML. This firm fixed-price delivery order, awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was funded by the Defense Logistics Agency and performed at the contractor's Park Ridge, Illinois facility.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceuticals and medical consumables to Department of Defense military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 through December 31, 2036, and includes a 30-month base period with three 30-month option periods. DMS Pharmaceutical Group serves as a regional prime vendor contractor under this program, leveraging its established performance distributing comprehensive pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support the diverse medical supply needs of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FSCB3?
SPE2DR26FSCB3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FSCB3 worth?
The government has obligated $10,245 on SPE2DR26FSCB3.
Is contract SPE2DR26FSCB3 an order under another contract?
Yes. SPE2DR26FSCB3 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCB3 competed?
The extent of competition for SPE2DR26FSCB3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award